|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 25.88 USD | +0.43% |
|
+2.63% | -2.79% |
| Market Cap | 4.41B 3.86B 3.56B 3.3B 6.27B 421B 6.36B 42.61B 16.58B 207B 16.57B 16.21B 716B | P/E 2026 * |
67x | P/E 2027 * | 35.3x |
|---|---|---|---|---|---|
| Enterprise Value | 3.45B 3.02B 2.78B 2.58B 4.9B 329B 4.97B 33.3B 12.96B 161B 12.95B 12.67B 560B | EV / Sales 2026 * |
2.78x | EV / Sales 2027 * | 2.32x |
| Free-Float |
99.68% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: ACADIA Pharmaceuticals Inc.
| 1 day | +0.37% | ||
| 1 week | +2.63% | ||
| Current month | +2.63% | ||
| 1 month | +19.65% | ||
| 3 months | +17.54% | ||
| 6 months | -5.31% | ||
| Current year | -2.79% |
| 1 week | 24.94 |  | 26.23 |
| 1 month | 20.84 | | 27.31 |
| Current year | 19.89 | | 27.81 |
| 1 year | 19.69 | | 28.35 |
| 3 years | 13.4 | | 33.99 |
| 5 years | 12.24 | | 33.99 |
| 10 years | 12.24 | | 58.72 |
| Manager | Title | Age | Since |
|---|---|---|---|
Catherine Adams
CEO | Chief Executive Officer | 55 | 20/09/2024 |
Mark Schneyer
DFI | Director of Finance/CFO | 52 | 10/09/2021 |
Scott Cenci
CTO | Chief Tech/Sci/R&D Officer | - | 04/08/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
Laura Brege
BRD | Director/Board Member | 68 | 01/05/2008 |
Stephen Biggar
CHM | Chairman | 55 | 10/06/2016 |
Edmund Harrigan
BRD | Director/Board Member | 73 | 25/11/2015 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 06-26 | Sell | Controller/Auditor | -11,421 | 0.0067% | ||
| 05-29 | Fiscal year | Director | 41,529 | 0.0243% | ||
| 05-29 | Other | Director | 0 | 0% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.43% | +2.63% | +24.35% | +6.41% | 4.41B | |
| -0.62% | +5.83% | +3.51% | +10.02% | 50.25B | |
| -0.31% | +0.92% | +415.41% | +616.18% | 40.39B | |
| +0.85% | +7.60% | +27.98% | -4.10% | 34.38B | |
| -0.87% | +8.22% | +27.97% | +62.70% | 34.4B | |
| +1.31% | -0.56% | +5.12% | +33.90% | 26.32B | |
| +1.86% | +1.83% | - | - | 16.64B | |
| -2.89% | +4.62% | +73.73% | +135.23% | 16.14B | |
| +0.64% | +0.82% | +14.66% | +21.82% | 13.71B | |
| +2.68% | +7.60% | +104.20% | +104.20% | 13.75B | |
| Average | +0.28% | +3.50% | +77.44% | +109.60% | 25.04B | |
| Weighted average by Cap. | +0.06% | +4.07% | +93.88% | +137.93% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 1.24B 1.09B 1B 929M 1.76B 118B 1.79B 11.99B 4.66B 58.12B 4.66B 4.56B 201B | 1.39B 1.22B 1.12B 1.04B 1.98B 133B 2.01B 13.46B 5.24B 65.29B 5.24B 5.12B 226B |
| Net income | 66M 57.8M 53.24M 49.42M 93.84M 6.3B 95.11M 637M 248M 3.09B 248M 242M 10.71B | 133M 117M 107M 99.64M 189M 12.69B 192M 1.28B 500M 6.23B 500M 489M 21.6B |
| Net Debt | -965M -845M -778M -722M -1.37B -92B -1.39B -9.31B -3.62B -45.16B -3.62B -3.54B -157B | -1.18B -1.03B -950M -881M -1.67B -112B -1.7B -11.37B -4.42B -55.12B -4.42B -4.32B -191B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 07/07/26 | $25.97 | +0.76% | 232,114 |
| 06/07/26 | $25.77 | -0.77% | 1,155,022 |
| 02/07/26 | $25.97 | +3.06% | 1,586,395 |
| 01/07/26 | $25.20 | -0.40% | 1,417,658 |
| 30/06/26 | $25.30 | +0.40% | 1,721,284 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- ACAD Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
